earnings
confidence medium
sentiment positive
materiality 0.75
Lumexa Imaging prelim Q4 rev at least $261M, FY rev at least $1.016B; guides FY 2026 rev $1.045-1.097B
Lumexa Imaging Holdings, Inc.
- Prelim Q4 2025 rev at least $261M (+5.2% YoY); adj. EBITDA at least $63M (+17% YoY).
- Prelim FY 2025 rev at least $1.016B (+7.1% YoY); adj. EBITDA at least $229M (+14% YoY).
- FY 2026 guidance: rev $1.045-1.097B, adj. EBITDA $234-242M (incl. ~$7M public co. costs).
- Net loss improved: FY 2025 prelim loss not larger than $43.8M vs $94.1M prior year.
- Opened 9 de novo centers in 2025; PET volumes up 17% consolidated; AI pilot in NJ.